Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1887 1
1889 2
1890 1
1891 2
1892 1
1893 2
1894 2
1895 1
1902 1
1903 1
1907 2
1908 1
1917 1
1923 1
1951 1
1954 2
1957 1
1958 1
1962 1
1963 2
1964 2
1965 1
1966 2
1967 1
1968 4
1969 4
1970 1
1972 5
1973 4
1974 1
1975 13
1976 12
1977 3
1978 6
1979 2
1980 1
1981 2
1982 3
1983 5
1986 1
1987 2
1988 2
1989 4
1990 3
1991 4
1992 4
1993 2
1994 4
1995 3
1996 2
1997 4
1998 1
1999 2
2000 7
2001 3
2002 5
2003 6
2004 6
2005 12
2006 16
2007 24
2008 28
2009 27
2010 25
2011 20
2012 13
2013 18
2014 13
2015 13
2016 9
2017 6
2018 20
2019 17
2020 12
2021 11
2022 25
2023 13
2024 14
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

481 results

Results by year

Filters applied: . Clear all
Page 1
Sickle cell disease.
Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. Kato GJ, et al. Among authors: smith wr. Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10. Nat Rev Dis Primers. 2018. PMID: 29542687 Free article. Review.
Apixaban versus warfarin in patients with atrial fibrillation.
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Granger CB, et al. N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27. N Engl J Med. 2011. PMID: 21870978 Free article. Clinical Trial.
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: smith wr. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Ataga KI, et al. Among authors: smith wr. N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3. N Engl J Med. 2017. PMID: 27959701 Free PMC article. Clinical Trial.
Orthogenomics: an update.
Matzko ME, Bowen TR, Smith WR. Matzko ME, et al. Among authors: smith wr. J Am Acad Orthop Surg. 2012 Aug;20(8):536-46. doi: 10.5435/JAAOS-20-08-536. J Am Acad Orthop Surg. 2012. PMID: 22855856 Review.
Fragility Fractures in Orthopaedics: An Update.
Hou Z, Mauffrey C, Smith WR, Scarlat MM. Hou Z, et al. Among authors: smith wr. Biomed Res Int. 2017;2017:1924069. doi: 10.1155/2017/1924069. Epub 2017 Jan 19. Biomed Res Int. 2017. PMID: 28197409 Free PMC article. No abstract available.
Prehospital central venous catheters.
Studer NM, Pickett JR, Winckler CJ, Smith WR, Cap AP, Cunningham CW. Studer NM, et al. Among authors: smith wr. Transfusion. 2024 Oct;64(10):1814-1816. doi: 10.1111/trf.17949. Epub 2024 Aug 30. Transfusion. 2024. PMID: 39215380 Review.
Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.
Abboud MR, Cançado RD, De Montalembert M, Smith WR, Rimawi H, Voskaridou E, Güvenç B, Ataga KI, Keefe D, Grosch K, Watson J, Reshetnyak E, Nassin ML, Dei-Adomakoh Y. Abboud MR, et al. Among authors: smith wr. Lancet Haematol. 2025 Apr;12(4):e248-e257. doi: 10.1016/S2352-3026(24)00384-3. Epub 2025 Mar 12. Lancet Haematol. 2025. PMID: 40088922 Clinical Trial.
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.
Idowu M, Otieno L, Dumitriu B, Lobo CLC, Thein SL, Andemariam B, Nnodu OE, Inati A, Glaros AK, Bartolucci P, Colombatti R, Taher AT, Abboud MR, Darbari D, Ataga KI, Antmen AB, Kuo KHM, de Souza Medina S, Oluyadi A, Iyer V, Morris S, Yates AM, Shao H, Patil S, Urbstonaitis R, Zaidi AU, Gheuens S, Smith WR. Idowu M, et al. Among authors: smith wr. Lancet Haematol. 2025 Jan;12(1):e35-e44. doi: 10.1016/S2352-3026(24)00319-3. Epub 2024 Dec 4. Lancet Haematol. 2025. PMID: 39644907 Clinical Trial.
Moral expertise without moral elitism.
Smith WR. Smith WR. Bioethics. 2023 Jul;37(6):564-574. doi: 10.1111/bioe.13034. Epub 2022 Apr 11. Bioethics. 2023. PMID: 35403726 Free PMC article.
481 results